Menu

1 / 3

Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial

New York Post·Mary Connelly·about 2 hours ago
#mtzowMgi
#nypost#alzheimer#disease#results#diranersen
Reading 0:00
15s threshold

See more of our coverage in your search results.

Is a major medical breakthrough on the horizon?

A new drug may prove to be a game changer in Alzheimer’s research following the results of an incredible trial.

Patients administered low-dose diranersen injections showed 54% less decline on a test of memory and thinking over nearly two years, suggesting the experimental treatment could slow the deadly disease more effectively than any therapy developed to date, per the Telegraph .

A new drug may prove to be a game changer in Alzheimer’s research following a major trial. Getty Images

It is also the first drug to show a decline in tau, a protein that forms harmful tangles linked to brain cell death.

The diranersen injections use gene-silencing technology to confront Alzheimer’s at its source, blocking the RNA messages that signal for brain cells to produce tau.

Biogen announced the exciting results on Tuesday, Nov.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.